Trial intelligence / Profile preview

Propofol with or without esketamine for outpatient pediatric sedation

ChiCTR2100048536Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Zhengzhou University
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of propofol and esketamine (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Sedation success rate and Incidence of adverse reactions. Planned start Jul 2021; status: not yet recruiting.

02

Drugs

propofolesketamine

Beyond the preview

Go deeper on ChiCTR2100048536.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100048536.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call